A. Mitropoulou

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab

Benjamin P. Cossins, T. Ceska, Anthony H Keeble, 2017, The Journal of Biological Chemistry.

Structure of a patient-derived antibody in complex with allergen reveals simultaneous conventional and superantigen-like recognition

L. James, A. Beavil, B. Sutton, 2018, Proceedings of the National Academy of Sciences.

Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody

A. Beavil, B. Sutton, R. Beavil, 2018, Scientific Reports.

Modulating co-translational protein folding by rational design and ribosome engineering

Lisa D. Cabrita, Tomasz Włodarski, J. Christodoulou, 2022, Nature Communications.

Extended evaluation of urinary multi-biomarker analyses of mycotoxins in Swedish adults and children

M. Solfrizzo, A. Mitropoulou, M. Olsen, 2018, World Mycotoxin Journal.

Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization

T. Ceska, A. Beavil, B. Sutton, 2020, Acta crystallographica. Section F, Structural biology communications.

CryoENsemble - a Bayesian approach for reweighting biomolecular structural ensembles using heterogeneous cryo-EM maps

Lisa D. Cabrita, Tomasz Włodarski, A. Mitropoulou, 2023, bioRxiv.